Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ABEO Abeona Therapeutics > Detailed Quotes

ABEO Abeona Therapeutics

Watchlist
2.760
-0.060-2.13%
Close  02/03 16:00 ET
2.7600.0000.00%
Post Mkt Price 02/03 16:00 ET
High
2.900
Open
2.770
Turnover
448.60K
Low
2.720
Pre Close
2.820
Volume
158.45K
Market Cap
47.41M
P/E(TTM)
Loss
52wk High
9.355
Shares
17.18M
P/E(Static)
Loss
52wk Low
2.340
Float Cap
35.81M
Bid/Ask %
87.50%
Historical High
171874.880
Shs Float
12.97M
Volume Ratio
0.92
Historical Low
2.340
Dividend TTM
--
Div Yield TTM
--
P/B
3.08
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.22%
Amplitude
6.38%
Avg Price
2.831
Lot Size
1
Float Cap
35.81M
Bid/Ask %
87.50%
Historical High
171874.880
Shs Float
12.97M
Volume Ratio
0.92
Historical Low
2.340
Dividend TTM
--
P/B
3.08
Dividend LFY
--
Turnover Ratio
1.22%
Amplitude
6.38%
Avg Price
2.831
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.
CEO: Mr. Vishwas Seshadri
Market: NASDAQ
Listing Date: 12/19/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist